DE60020260D1 - Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent - Google Patents

Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent

Info

Publication number
DE60020260D1
DE60020260D1 DE60020260T DE60020260T DE60020260D1 DE 60020260 D1 DE60020260 D1 DE 60020260D1 DE 60020260 T DE60020260 T DE 60020260T DE 60020260 T DE60020260 T DE 60020260T DE 60020260 D1 DE60020260 D1 DE 60020260D1
Authority
DE
Germany
Prior art keywords
alkyl
alkynyl
alkenyl
alpha
hydrocarbyl substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60020260T
Other languages
English (en)
Other versions
DE60020260T2 (de
Inventor
Jan Loozen
Herman Veeneman
Gerardus Schoonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60020260D1 publication Critical patent/DE60020260D1/de
Publication of DE60020260T2 publication Critical patent/DE60020260T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60020260T 1999-09-06 2000-08-28 Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent Expired - Lifetime DE60020260T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06
EP99202900 1999-09-06
PCT/EP2000/008406 WO2001018027A1 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Publications (2)

Publication Number Publication Date
DE60020260D1 true DE60020260D1 (de) 2005-06-23
DE60020260T2 DE60020260T2 (de) 2006-01-19

Family

ID=8240610

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60020260T Expired - Lifetime DE60020260T2 (de) 1999-09-06 2000-08-28 Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent

Country Status (24)

Country Link
US (1) US6677329B1 (de)
EP (1) EP1224204B1 (de)
JP (1) JP2003508541A (de)
KR (1) KR20020092907A (de)
CN (2) CN100354299C (de)
AT (1) ATE295851T1 (de)
AU (1) AU770331B2 (de)
BR (1) BR0013769A (de)
CA (1) CA2382489C (de)
CZ (1) CZ2002831A3 (de)
DE (1) DE60020260T2 (de)
EC (1) ECSP013947A (de)
ES (1) ES2241657T3 (de)
HU (1) HUP0202595A3 (de)
IL (2) IL148116A0 (de)
MX (1) MXPA02001831A (de)
NO (1) NO20021079L (de)
NZ (1) NZ517281A (de)
PL (1) PL353826A1 (de)
RU (1) RU2245886C2 (de)
SK (1) SK3282002A3 (de)
TR (1) TR200200575T2 (de)
WO (1) WO2001018027A1 (de)
ZA (1) ZA200201250B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
HUP0202595A3 (en) * 1999-09-06 2004-06-28 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
US7041839B2 (en) * 2000-06-22 2006-05-09 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
WO2002010188A1 (en) * 2000-07-28 2002-02-07 Akzo Nobel N.V. 16alpha-methyl or ethyl substituted estrogens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US11034716B2 (en) * 2016-03-03 2021-06-15 Crystal Pharma, S.A.U. Process and new intermediates for the preparation of 11-methylene steroids
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1112840A (en) 1964-04-07 1968-05-08 Res Inst Medicine Chem Steroids having pro-oestrogenic activity
US3465010A (en) 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
ZA941464B (en) 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
TR200002593T2 (tr) 1998-03-09 2000-12-21 Akzo Nobel N.V. Yeni bir gebelik önleme kiti
HUP0202595A3 (en) * 1999-09-06 2004-06-28 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
TR200200575T2 (tr) 2002-06-21
NZ517281A (en) 2003-09-26
ECSP013947A (es) 2002-09-27
CN100354299C (zh) 2007-12-12
JP2003508541A (ja) 2003-03-04
ATE295851T1 (de) 2005-06-15
PL353826A1 (en) 2003-12-01
SK3282002A3 (en) 2002-06-04
US6677329B1 (en) 2004-01-13
DE60020260T2 (de) 2006-01-19
EP1224204A1 (de) 2002-07-24
AU7511700A (en) 2001-04-10
IL148116A0 (en) 2002-09-12
HUP0202595A2 (hu) 2002-12-28
CZ2002831A3 (cs) 2002-05-15
CN1637016A (zh) 2005-07-13
KR20020092907A (ko) 2002-12-12
EP1224204B1 (de) 2005-05-18
RU2245886C2 (ru) 2005-02-10
ZA200201250B (en) 2003-07-30
HUP0202595A3 (en) 2004-06-28
AU770331B2 (en) 2004-02-19
CA2382489A1 (en) 2001-03-15
BR0013769A (pt) 2002-04-30
WO2001018027A1 (en) 2001-03-15
NO20021079D0 (no) 2002-03-05
IL148116A (en) 2006-10-31
MXPA02001831A (es) 2002-10-23
CN1372565A (zh) 2002-10-02
CA2382489C (en) 2008-03-11
CN1185249C (zh) 2005-01-19
NO20021079L (no) 2002-04-29
ES2241657T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
DE60020260D1 (de) Nicht-aromatische estrogenische steroide mit einem 11-hydrocarbyl substituent
DE69327096D1 (de) 17-substituierte steroide, verwendbar bei behandlung von krebs
DE122004000011I2 (de) Steroide Derivate.
DE69634039D1 (de) Neuroaktive steroide der androstan- und pregnanreihe
RS20070075A (en) 15beta-substituted steroids having selective estrogenic activity
NO961693L (no) Delta16-umettede C17-heterocykliske steroider som er anvendbare som steroid C17-20-lyaseinhibitorer
DK0469548T3 (da) 4-Amino-delta4-steroider og deres anvendelse som inhibitorer af 5alfa-reduktase
RU2002108723A (ru) Неароматические эстрогенные стероиды с углеводородным заместителем в положении 11
DK165987C (da) 14-azido-steroider, der er anvendelige som mellemprodukter
DK0520879T3 (da) 16-methylsubstituerede derivater af pregna-1,4-dien-3,20-dion, deres fremstilling, deres anvendelse til fremstilling af 16-methylensteroider og hidtil ukendte mellemprodukter
ATE154606T1 (de) 2beta,19-methylenamin überbrückte steroide als aromatasehemmer
NO20020260L (no) 11<beta>-aryl-17,17-spirotiolansubstituerte steroider
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
FI946189A (fi) 5-alfa-reduktaasi-inhibiittoreina käyttökelpoiset 17-alkyyliketonisteroidit
DK352086A (da) Steroide aromatase-inhibitorer
CO5261633A1 (es) Compuestos estrogenicos
CO5251432A1 (es) Derivados de 3-metileno esteroides
MXPA03005224A (es) Esteroides de metileno como androgenos novedosos.
RU2000116237A (ru) Ингибиторы стероидсульфатазы
TW343976B (en) 17-substituted steroids useful in cancer treatment
YU151591A (sh) Postupak za etinilovanje 17-ketosteroida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL